Buscar resultados de ensayos clínicos
Hemophilia A - 41 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Study to Establish Bioequivalence of ReFacto AF (BDDrFVIII) With Advate (FLrFVIII) in Hemophilia A Condición: Hemophilia A Fecha: 2005-08-30 Intervenciones:
|
Completed |
Nombre del estudio: Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects Compared to That of Episodic Treatment Condición: Hemophilia A Fecha: 2008-02-04 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A Condición: Hemophilia A Fecha: 2012-03-28 Intervenciones: Biological: BAY94-9027 Intravenous infusion of BAY94-9027 |
Recruiting |
Nombre del estudio: Extension at 10 Years of the: "Observational Study Evaluating Efficacy and Costs of Secondary Prophylaxis vs On-demand Therapy With Kogenate Bayer in Patients With Severe Haemophilia A." Condición: Hemophilia A Fecha: 2015-10-20 Intervenciones:
|
Completed |
Nombre del estudio: Study of Biostate® in Children With Hemophilia A Condición: Hemophilia A Fecha: 2010-10-01 Intervenciones: Biological: Biostate 1 dose of 50 IU FVIII/kg body weight of Biostate administered intravenously on Day |
Completed |
Nombre del estudio: Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic Surgery Condición: Hemophilia A Fecha: 2006-07-25 Intervenciones:
|
Completed |
Nombre del estudio: Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery Condición: Hemophilia A Fecha: 2005-10-20 Intervenciones: Biological: ReFacto AF |
Recruiting |
Nombre del estudio: A Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants Without Inhibitors Condición: Hemophilia A Fecha: 2016-07-26 Intervenciones: Drug: Emicizumab Participants will receive emicizumab prophylaxis at the specified dose subcutaneously u |
Completed |
Nombre del estudio: Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Patients With Hemophilia A Condición: Hemophilia A Fecha: 2012-03-22 Intervenciones: Drug: GreenGene Dose : 10 ~ 50IU/kg Administration method : intravenous infusion or bolus |
Enrolling by invitation |
Nombre del estudio: Platelet Function in Patients With Hemophilia A Condición: Hemophilia A Fecha: 2014-03-19 |